Articles
A New Option for Intermediate-Risk Prostate Cancer — and Why It Matters
A New Option for Intermediate-Risk Prostate Cancer — and Why It Matters
New Prostate Cancer Guidelines and ASPI Pathway
New Prostate Cancer Guidelines and ASPI Pathway: new guidelines for early low risk prostate cancer
Prostate Cancer and GU Pathology 2nd Opinions
Prostate Cancer and GU Pathology 2nd Opinions: Recommended providers for GU/prostate cancer pathology 2nd Opinions
PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life
PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life
Rarity Life Magazine Featuring Rick Davis
Rarity Life Magazine interviews AnCan Founder, Rick Davis on the value of virtual peer support and how AnCan came to be,
2nd Opinions for MRIs
2nd Opinions for MRIs
AnCan GU ASCO26 survivorship poster: participants strongly endorse our Groups
AnCan GU ASCO26 survivorship poster: participants strongly endorse our Groups – 99% recommend AnCan Groups.
Is It OK to Take Supplements After a Prostate Cancer Diagnosis?
Is It OK to Take Supplements After a Prostate Cancer Diagnosis? What supplements are safe and advised… and what may be not.
Article Review – A Clear Guide to PCa Biomarkers
Article Review – A Clear Guide to PCa Biomarkers
FDA Position on Cannabis and Cannabinoids
FDA Position on Cannabis and Cannabinoids interpreted by an AnCan peer expert.
Genomic Risk Classifiers: Similar, but Not the Same
Genomic Risk Classifiers: Similar, but Not the Same
CNTV’s “Best of the Nation” featuring Rick Davis
CNTV’s “Best of the Nation” featuring Rick Davis